|
Market Cap (4-Jul) $1,667,200 (1,583rd) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 21,427 |
Shortsold (14-Feb) 10,000,000 (0.20%) (406th) |
|
52w High $0.020 |
52w Low $0.004 |
P/E - |
EPS -0.04 |
ADR released this announcement to the ASX on 23 March 2023, 12:01. The announcement is not marked as price sensitive, and is 4 page(s) in length and 303.63kb in size.
You can view all announcements from ADR and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from ADR | |
|---|---|
| Application for quotation of securities - ADR | 28 June 2023, 16:25 |
| Change of Auditor | 27 June 2023, 9:41 |
| Notification of cessation of securities - ADR | 11 May 2023, 13:49 |
| US FDA clearance of Adherium's Hailie for Teva inhalers | 23 March 2023, 12:01 |
| Ceasing to be a substantial holder | 27 February 2023, 20:19 |
| Half Yearly Report and Accounts | 27 February 2023, 13:50 |
| Change in substantial holding | 21 February 2023, 7:48 |
You must be logged in to post a reply.
Adherium 